HLS:CC News and Press, HLS Therapeutics Inc.

HLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug Plan Canada NewsWire With the addition of Alberta's public plan, Vascepa will be available to more than 90% of Canadians who are eligible and covered by a public or private plan. ...

HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO , July 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 fiscal 2024 financial results on Thur...

A look at the top 10 most actives in Canada Alaska Energy Metals Corporation (AEMC) rose 1.7% to $0.3 on volume of 2,135,498 shares BetaPro Natural Gas Leveraged Daily Bull ETF (HNU) fell 6.0% to $2.83 on volume of 1,507,663 shares Givex Corp. (GIVX) rose 0.0% to $0.88 on volume of 1,150,...

HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust Canada NewsWire Total consideration of up to $45.75 million , which consists of upfront cash, sales-based milestone payments and DRI Healthcare's assumption of future mi...

A look at the top 10 most actives in Canada BlackBerry Limited (BB) rose 10.5% to $3.36 on volume of 12,209,225 shares Solstice Gold Corp. (SGC) fell 33.3% to $0.02 on volume of 11,588,936 shares HIGH INTEREST SAVINGS ACCOUNT FUND (HISA) fell 0.3% to $50.01 on volume of 10,628,355 shares ...

Gold Springs Resource Corp. (GRC:CA) is expected to report for Q1 2024 Primo Water Corporation (PRMW:CA) is expected to report $0.18 for Q1 2024 Greenlane Renewables Inc. (GRN:CA) is expected to report $-0.01 for Q1 2024 Kelso Technologies Inc. (KLS:CA) is expected to report for Q1 20...

HLS Therapeutics Announces Q1 2024 Financial Results Canada NewsWire TORONTO , May 9, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders...

HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO , April 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 fiscal 2024 financial results on Thursday...

HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire TORONTO , April 9, 2024 /CNW/ - HLS Therapeutics I...

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups Canada NewsWire Findings Presented on VASCEPA Utility in REDUCE-IT Patient Subgroups by Baseline High/Low Lp(a), LDL-C Levels Lp...